A pharmaceutical expert, Mr Leslie N.O. Vanderpuije has advocated that the Free Primary Healthcare (FPHC) initiative can only achieve its intended impact when patients have reliable access to quality-assured medicines, receive appropriate treatment and are able to continue their medication without interruption.
Delivering the keynote address at the National Pharmacy Heads Retreat 2026 at Dr. Agyemang Badu Akosa Conference Hall at Pantang, the pharmaceutical supply chain consultant and Managing Director of NovoMed Pharma Ltd., challenged heads of pharmaceutical services to reposition their operations to make medicine availability, patient safety and continuity of care central to primary healthcare delivery.
Speaking on the theme, “Reorienting Pharmaceutical Services Towards Free Primary Healthcare for Accelerated Progress Towards UHC and the Health-Related Sustainable Development Goals,” Mr. Vanderpuije asserted that the success of Free Primary Healthcare should ultimately be measured by what patients experience at the point of care.
Using the example of an imaginary 45-year-old patient, Naa Korkoi, who visits a health centre to refill her blood-pressure medication only to discover that the prescribed medicine is unavailable, he illustrated the practical consequences of weaknesses in the medicines supply chain.
The patient is consequently required to travel to another town and find money to purchase the medicine, potentially placing her treatment at risk if she cannot afford the additional expense.
He used the scenario to demonstrate how gaps in medicine availability and affordability can undermine the objectives of a healthcare policy, emphasising that removing financial barriers to healthcare must be accompanied by dependable systems that ensure patients receive the medicines they need.
Mr. Vanderpuije noted that the Free Primary Healthcare initiative, the Ghana Medical Trust Fund (MahamaCares) and the 24-hour health service policy were creating new demands on pharmaceutical services. He called for stronger alignment between national health priorities and the entire medicines management pathway, from selection and procurement to distribution, prescribing, dispensing and monitoring.
He therefore outlined six practical shifts that should define the patient experience under a reoriented pharmaceutical service. These shifts include ensuring that patients receive safe, effective and appropriate medicines throughout their treatment; maintaining the availability of essential medicines, particularly for people managing long-term conditions; and strengthening pharmaceutical care beyond dispensing through prescription reviews, counselling and adherence support.
Mr Vanderpuije further emphasised the need to maintain continuity of medicines and treatment information during patient referrals, transfers and discharge, use service and supply data to identify gaps and prevent harm, and establish clear responsibilities for Pharmacy Heads, Drug and Therapeutics Committees and clinical teams.
To translate these changes into practice, he consequently identified four critical requirements: reliable access to medicines supported by dependable data and sustainable financing; stronger medication management and patient safety systems; clear standards and accountable governance; and the alignment of professional responsibilities with the necessary authority, staffing and resources.
Touching on medicine availability, Mr. Vanderpuije stressed the importance of strengthening forecasting, procurement, storage and distribution systems, particularly at health centres and Community-based Health Planning and Services (CHPS) compounds. He urged facilities to move beyond routine stock counts and monitor indicators such as stock-out days, order fill rates, expired medicines and unserved prescriptions to establish whether patients were obtaining the medicines they needed.
He further called for improved pharmaceutical workforce capacity at the primary care level, including appropriate training, supervision and support for pharmacy technicians, dispensing staff and designated health workers at CHPS compounds without dedicated pharmacy personnel.
Addressing the sustainability of medicine supplies, he underscored the importance of sound management of the Drug Revolving Fund (DRF), highlighting efficient procurement, appropriate pricing, prudent financial management, timely National Health Insurance Scheme reimbursements and reduced losses and expiries as essential measures.
He also called for stronger medication safety practices through prescription reviews, antimicrobial stewardship, adverse drug reaction reporting and the systematic review of medication errors to promote institutional learning and prevent avoidable harm.
On standards and accountability, he proposed a renewed national implementation process beginning with a baseline assessment, followed by staff orientation, supportive supervision and a repeat assessment after six months to measure progress while stressing that professional responsibilities must be matched with the authority and resources required to deliver results.
In his call to action, he urged participants to agree on clear responsibilities for Pharmacy Heads under Free Primary Healthcare, the Ghana Medical Trust Fund (MahamaCares) and 24-hour service delivery; develop a workforce and service plan; strengthen medicine availability, data management and standards; and establish clear implementation responsibilities, timelines and reporting arrangements.
He thus maintained that the ultimate measure of the retreat's success should be the patient's ability to obtain the right medicine when needed, without financial hardship, use it safely and continue treatment without interruption.

